# Dilshani Induruwage

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dilshani-induruwage/

## Facts

| Field | Value |
| --- | --- |
| Citations | 197 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 7 |
| i10-index | 6 |
| Last Known Institution | BC Cancer Agency |
| OpenAlex ID | https://openalex.org/A5036433757 |
| ORCID iD | 0009-0002-0982-7816 |
| Works | 17 |

## Researcher papers

- [Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool](https://scholariq.org/papers/improving-treatment-decisions-using-personalized-risk-assessment-from-the/)
- [Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy](https://scholariq.org/papers/anti-pla2r-antibody-levels-and-clinical-risk-factors-for-treatment-nonresponse/)
- [Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada](https://scholariq.org/papers/disease-specific-incident-glomerulonephritis-displays-geographic-clustering-in/)
- [Socioeconomic Position and Incidence of Glomerular Diseases](https://scholariq.org/papers/socioeconomic-position-and-incidence-of-glomerular-diseases/)
- [Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases](https://scholariq.org/papers/evaluating-the-risk-of-cardiovascular-events-associated-with-different/)
- [Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts](https://scholariq.org/papers/regional-variation-in-hemoglobin-distribution-among-individuals-with-ckd-the-isn/)
- [Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy](https://scholariq.org/papers/predicting-remission-in-antiphospholipase-a2-receptor-antibody-associated/)
- [Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN](https://scholariq.org/papers/clinical-and-histologic-predictors-of-kidney-outcomes-in-c3-glomerulopathy-and/)
- [Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study](https://scholariq.org/papers/incidence-of-and-risk-factors-for-active-tuberculosis-disease-in-individuals/)
- [Adverse changes in key chronic kidney disease care outcome metrics since the onset of the COVID-19 pandemic: experience from an established provincial renal program](https://scholariq.org/papers/adverse-changes-in-key-chronic-kidney-disease-care-outcome-metrics-since-the/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [BC Cancer Agency](https://scholariq.org/institutions/bc-cancer-agency/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.